Change of Advisor

EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces the appointment of Nplus1 Singer Advisory LLP ("N+1 Singer") as Nominated Adviser and sole Broker to the Company with immediate effect.

EKF Diagnostics Holdings plc Julian Baines, CEO Richard Evans, Finance Director and COO	00 44 29 2071 0570
N+1 Singer Alex Price / Alex Laughton-Scott	00 44 20 7496 3000
Walbrook PR Limited Paul McManus Lianne Cawthorne	00 44 20 7933 8780 or ekf@walbrookpr.com 00 44 7980 541 893 00 44 7584 391 303

Back to Listing Previous Next

EKF Diagnostics

EKF Diagnostics Holdings plc is a manufacturer and distrbutor of IVD products. It has three core divisions: Point of Care including hemoglobin and HbA1c analyzers; Central Laboratory including the manufacture of enzymes and clinical chemistry; and Molecular Diagnostics which incorporates a unique DNA enrichment technology, PointMan, and a portfolio of molecular testing services.

News & events

Mike Salter heads EKF US & EKF Life Sciences

Mike Salter appointed as President, EKF USA and EKF Life Sciences

EKF Procalcitonin Assay FDA cleared and validated for Beckman AU chemistry analyzers

User defined application available on Beckman AU clinical chemistry analyzers for LiquiColor® Procalcitonin (PCT) assay enabling quick and effective sepsis identification.

Diabetic ketoacidosis assay collaboration between Ortho Clinical Diagnostics and EKF Diagnostics

EKF’s Beta-Hydroxybutyrate LiquiColor^® assay for detection of predominant ketone body is now available on Ortho’s VITROS^® 4600 Chemistry System and VITROS^® 5600 Integrated System.

EKF at MEDICA - November 2017

MEDICA is the world’s largest medical trade fair. For more than 40 years it has been firmly established on every expert’s calendar attracting over 40,000 delegates and over 5,000 exhibitors from 70 countries in 17 halls.

Diabetes Testing Methods: What is HbA1c and how can it build upon traditional glucose testing methods?

HbA1c meassurement is a diabetes testing method, provides insight into chronic hyperglycemia rather than testing glucose.